Stepwise control of osteogenic differentiation by 5-HT(2B) receptor signaling: nitric oxide production and phospholipase A2 activation.
about
The serotonin 5-HT2B receptor controls bone mass via osteoblast recruitment and proliferation.The emerging role of serotonin (5-hydroxytryptamine) in the skeleton and its mediation of the skeletal effects of low-density lipoprotein receptor-related protein 5 (LRP5).Serotonergic 5-HT(2B) receptor controls tissue-nonspecific alkaline phosphatase activity in osteoblasts via eicosanoids and phosphatidylinositol-specific phospholipase CSerotonin regulates osteoblast proliferation and function in vitro.Update in serotonin and bone.Skeletal effects of serotonin (5-hydroxytryptamine) transporter inhibition: evidence from in vitro and animal-based studiesEvaluation of the effect of selective serotonin reuptake inhibitors on bone mineral density: an observational cross-sectional study.Serotonin: good or bad for bone.Possible mechanisms for the skeletal effects of antipsychotics in children and adolescentsRates of bone loss among women initiating antidepressant medication use in midlifeEssential Roles of Dopamine and Serotonin in Tooth Repair: Functional Interplay Between Odontogenic Stem Cells and Platelets.Serotonin Inhibits Osteoblast Differentiation and Bone Regeneration in Rats.Serotonin transporter and receptor expression in osteocytic MLO-Y4 cells.Serotonin 2B receptor (5-HT2B R) signals through prostacyclin and PPAR-ß/δ in osteoblastsEnamel alterations in serotonin 2B receptor knockout mice.The ionic products of bioactive glass particle dissolution enhance periodontal ligament fibroblast osteocalcin expression and enhance early mineralized tissue development.
P2860
Q33617543-AF62FDF2-7D1B-42B7-9498-8A7DA1400BC7Q33635906-715470BF-E599-4901-97D5-34353A5D6E05Q34074295-3E734DC7-9819-4E50-AB08-D658E4C56EC4Q34083546-A294C5D9-5386-464F-8CFC-E2DD79978164Q34113148-9A46E32C-0666-467D-B483-78C1F7DF0C71Q34140313-9E0EADF9-CA16-4729-B73B-D2FEAFEB7C46Q34863279-4C2F8484-1976-4763-B040-74FD311FEBE9Q37056379-A0E2755D-CF49-42E6-A0BA-EF064A039C40Q37247927-74D7B663-584E-45C6-B068-25D90C9CE769Q37275988-C2F7E378-F03D-4FB5-A57F-D40901C50A13Q38888385-958CE3C6-4A7A-45F0-88F9-49A3EB9EFD84Q40181802-982FFFAC-1DE6-4C40-ADAA-93C0F907449FQ40248681-C727C163-0654-471B-BA14-D228922C438CQ42629276-D9C5E764-82A3-4BD8-9577-E25BC49F95DAQ46291773-074080C7-29DE-424E-90AC-E3464475A497Q46819397-1B376F71-16CE-48CA-A39C-326B7F292858
P2860
Stepwise control of osteogenic differentiation by 5-HT(2B) receptor signaling: nitric oxide production and phospholipase A2 activation.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Stepwise control of osteogenic ...... d phospholipase A2 activation.
@en
type
label
Stepwise control of osteogenic ...... d phospholipase A2 activation.
@en
prefLabel
Stepwise control of osteogenic ...... d phospholipase A2 activation.
@en
P2093
P1433
P1476
Stepwise control of osteogenic ...... nd phospholipase A2 activation
@en
P2093
P304
P356
10.1016/J.CELLSIG.2005.06.006
P577
2005-07-12T00:00:00Z